Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Exenatide in combination therapy: small study, big market, and many unanswered questions.

Malozowski S.

Ann Intern Med. 2007 Apr 3;146(7):527-8. No abstract available.

PMID:
17404355
2.

Summaries for patients. Exenatide therapy for type 2 diabetes.

[No authors listed]

Ann Intern Med. 2007 Apr 3;146(7):I18. No abstract available.

PMID:
17404346
3.
4.

[Type 2 diabetic patient with reduced beta-cell function. New substance class: incretin-mimetics].

[No authors listed]

MMW Fortschr Med. 2005 Aug 4;147(31-32):55. German. No abstract available.

PMID:
16128203
5.

Summaries for patients: Does adding exenatide to insulin treatment benefit patients with type 2 diabetes?

[No authors listed]

Ann Intern Med. 2011 Jan 18;154(2):I-40. doi: 10.7326/0003-4819-154-2-201101180-00301. Epub 2010 Dec 6. No abstract available.

PMID:
21135289
7.

Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.

Pinelli NR, Cha R, Brown MB, Jaber LA.

Ann Pharmacother. 2008 Nov;42(11):1541-51. doi: 10.1345/aph.1L198. Epub 2008 Oct 28.

PMID:
18957626
8.

Exenatide and acute pancreatitis.

Tripathy NR, Basha S, Jain R, Shetty S, Ramachandran A.

J Assoc Physicians India. 2008 Dec;56:987-8.

PMID:
19322980
10.

Exenatide (Byetta) for type 2 diabetes.

[No authors listed]

Med Lett Drugs Ther. 2005 Jun 6;47(1210):45-6.

PMID:
15933616
11.

Missing the point: substituting exenatide for nonoptimized insulin: going from bad to worse!

Rosenstock J, Fonseca V.

Diabetes Care. 2007 Nov;30(11):2972-3. No abstract available.

PMID:
17965313
12.

Exenatide: new drug. Type 2 diabetes for some overweight patients.

[No authors listed]

Prescrire Int. 2007 Dec;16(92):228-31.

PMID:
18087791
13.

Drugs for diabetes.

Abramowicz M, Zuccotti G; Medical Letter.

Treat Guidel Med Lett. 2005 Aug;3(36):57-62. No abstract available.

PMID:
16012392
14.

[Improved blood sugar control plus weight loss].

Göke B.

MMW Fortschr Med. 2006 Aug 17;148(33-34):51. German. No abstract available.

PMID:
16981389
15.

[Exenatide convinces in a six-month study: HbA1c sunk significantly].

[No authors listed]

MMW Fortschr Med. 2009 May 7;151(19):51. German. No abstract available.

PMID:
19827448
16.

[Treatment of type 2 diabetes with new oral antihyperglycaemic drugs].

Seissler J.

MMW Fortschr Med. 2008 May 1;150(18):27-31. German. No abstract available.

PMID:
18533605
17.

[Exenatide--an alternative to insulin in the treatment of type 2 diabetes?].

Kjeldsen R, Sandbaek A.

Ugeskr Laeger. 2008 Sep 22;170(39):3039-43. Review. Danish.

PMID:
18822227
18.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. doi: 10.1016/j.clinthera.2008.08.006. Erratum in: Clin Ther. 2008 Oct;30(10):1937.

PMID:
18803987
19.

Exenatide and rare adverse events.

Ahmad SR, Swann J.

N Engl J Med. 2008 May 1;358(18):1970-1; discussion 1971-2. No abstract available.

PMID:
18456920
20.

Efficacy and safety of exenatide administered before the two largest daily meals of Latin American patients with type 2 diabetes.

Forti A, Garcia EG, Yu MB, Jimenez MC, Brodows RG, Oliveira JH.

Curr Med Res Opin. 2008 Sep;24(9):2437-47. doi: 10.1185/03007990802282398 . Epub 2008 Jul 24.

PMID:
18662495
Items per page

Supplemental Content

Write to the Help Desk